The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.

Pauline DürrKatja SchlichtigCarolin KelzBirgit DeutschRenke MaasMichael J EckartJochen WilkeHarald WagnerKerstin WolffCaroline PreußValeska BrücklNorbert MeidenbauerChristian StaerkAndreas MayrRainer FietkauPeter J GoebellFrank KunathMatthias W BeckmannAndreas MackensenMarkus F NeurathMarianne PavelFrank DörjeMartin F Fromm

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)

Treatment with oral anticancer drugs is associated with a broad range of medication errors and side effects. An intensified clinical pharmacological/pharmaceutical care has considerable, positive effects on the number of medication errors, patient treatment perception, and severe side effects.

Keyphrases

healthcare
patient reported outcomes
adverse drug
palliative care
phase iii
clinical trial
quality improvement
patient safety
phase ii
emergency department
double blind
study protocol
case report
early onset
affordable care act
placebo controlled
health insurance
replacement therapy